Xact Kapitalforvaltning AB Boosts Stake in M.D.C. Holdings, Inc. (NYSE:MDC)

Xact Kapitalforvaltning AB boosted its position in shares of M.D.C. Holdings, Inc. (NYSE:MDC) by 8.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,774 shares of the construction company’s stock after purchasing an additional 1,094 shares during the period. Xact Kapitalforvaltning AB’s holdings in M.D.C. were worth $429,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of MDC. Comerica Bank lifted its position in shares of M.D.C. by 0.7% in the 4th quarter. Comerica Bank now owns 49,645 shares of the construction company’s stock worth $1,522,000 after purchasing an additional 338 shares during the period. CIBC Private Wealth Group LLC increased its stake in shares of M.D.C. by 1.0% in the fourth quarter. CIBC Private Wealth Group LLC now owns 36,901 shares of the construction company’s stock worth $1,037,000 after acquiring an additional 350 shares during the period. Piedmont Investment Advisors Inc. boosted its holdings in M.D.C. by 3.6% during the fourth quarter. Piedmont Investment Advisors Inc. now owns 10,780 shares of the construction company’s stock worth $303,000 after buying an additional 378 shares in the last quarter. Legal & General Group Plc boosted its holdings in M.D.C. by 0.4% during the fourth quarter. Legal & General Group Plc now owns 108,282 shares of the construction company’s stock worth $3,047,000 after buying an additional 454 shares in the last quarter. Finally, Magnus Financial Group LLC boosted its holdings in M.D.C. by 8.0% during the first quarter. Magnus Financial Group LLC now owns 7,996 shares of the construction company’s stock worth $232,000 after buying an additional 592 shares in the last quarter. Institutional investors own 74.70% of the company’s stock.

Shares of M.D.C. stock traded up $0.09 during trading on Friday, reaching $33.52. The company’s stock had a trading volume of 6,388 shares, compared to its average volume of 350,988. The stock has a market capitalization of $2.05 billion, a price-to-earnings ratio of 9.10, a PEG ratio of 1.44 and a beta of 1.19. M.D.C. Holdings, Inc. has a fifty-two week low of $25.14 and a fifty-two week high of $33.82. The company has a debt-to-equity ratio of 0.68, a current ratio of 8.58 and a quick ratio of 2.19.

M.D.C. (NYSE:MDC) last announced its quarterly earnings data on Tuesday, April 30th. The construction company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.05. M.D.C. had a net margin of 6.90% and a return on equity of 14.20%. The company had revenue of $647.28 million for the quarter, compared to analysts’ expectations of $597.26 million. During the same period in the previous year, the company posted $0.63 EPS. M.D.C.’s revenue was up 6.5% compared to the same quarter last year. Analysts anticipate that M.D.C. Holdings, Inc. will post 3.16 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 29th. Investors of record on Wednesday, May 15th were given a $0.30 dividend. The ex-dividend date was Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 3.58%. M.D.C.’s dividend payout ratio is presently 32.70%.

In related news, Director Herbert T. Buchwald sold 30,618 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $32.38, for a total transaction of $991,410.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Larry A. Mizel sold 35,000 shares of the stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $32.46, for a total transaction of $1,136,100.00. Following the sale, the chairman now directly owns 160,958 shares of the company’s stock, valued at approximately $5,224,696.68. The disclosure for this sale can be found here. Insiders sold a total of 154,120 shares of company stock worth $4,963,135 over the last quarter. Insiders own 26.30% of the company’s stock.

Several equities analysts have issued reports on the stock. Zacks Investment Research downgraded shares of M.D.C. from a “buy” rating to a “hold” rating in a report on Saturday, May 4th. Wedbush restated a “neutral” rating and set a $30.00 price objective on shares of M.D.C. in a research report on Wednesday, May 1st. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. M.D.C. currently has a consensus rating of “Hold” and a consensus price target of $32.40.

WARNING: This article was posted by Riverton Roll and is the sole property of of Riverton Roll. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://rivertonroll.com/news/2019/06/14/xact-kapitalforvaltning-ab-boosts-stake-in-m-d-c-holdings-inc-nysemdc.html.

M.D.C. Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Read More: Outperform Rating

Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC).

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.